The Intercept @theintercept
Last Friday’s announcement that the new medicine molnupiravir cut the risk of hospitalization among clinical trial participants with moderate or mild illness in half could have huge implications for the course of the coronavirus pandemic. https://t.co/UZbOucbxba — PolitiTweet.org